Targeted oncology treatments are seeing improved efficacy rates as hospital networks standardize point-of-care genetic sequencing.
Diagnostic Velocity and Patient Outcomes
By reducing variant interpretation latency from weeks to hours, clinical teams can deploy targeted therapies prior to secondary disease progression.